AquaBounty headed for commercial GM farmed salmon production with 'strong balance sheet'

The company stated it has 'fortified' its balance sheet despite increases in net losses and capital costs.

The company's AquAdvantage salmon will represent the first sale of a genetically engineered animal protein in the United States.
The company's AquAdvantage salmon will represent the first sale of a genetically engineered animal protein in the United States.Foto: AquaBounty
Published 3 November 2020, 23:27Updated 4 November 2020, 13:00